For individuals who developed cancer after taking Zantac or other ranitidine medication, multiple Zantac lawsuits have now been filed across the country accusing drug makers of manufacturing, marketing and selling a product they knew or should have known had a chemical known to cause cancer, yet did nothing to warn consumers. In February, 2020, the JPML centralized the Zantac Products Liability Litigation in the Southern District of Florida before Judge Robin L. Rosenberg.
Due to the nationwide COVID-19 pandemic and to comport with the stay at home order, Judge Rosenberg issued a pretrial order on April 3, 2020 indicating that Zanatc lawsuits will continue to move forward via video conferencing. The disruption caused by the COVID-19 outbreak will not substantially delay this litigation thanks to the order.
The original initial conference has been rescheduled for May 12, 2020. Interviews for leadership positions for plaintiffs’ counsel has been rescheduled for May 6 and May 7, 2020. All of these will be conducted using the new video conferencing system as previously mentioned.
Currently, there are around 140 cases filed throughout the federal court system. However, given the FDA’s withdrawal of these medications from the market and the large number of individuals who used them, there could be potentially thousands of cases filed in the next few years.
How we can help if you believe you may have a legal claim:
Borgess Law, LLC is currently reviewing potential legal claims for individuals who have been diagnosed with stomach, small intestine, colorectal, esophageal, liver or other cancers after taking Zantac or other ranitidine medication. There is no charge for this review.
Attorney Pamela A. Borgess, the founder of Borgess Law, LLC, has extensive experience with numerous national high-profile defective medical drug/device cases and can discuss your legal options. For more information about the Zantac litigation or to discuss a potential claim, contact Borgess Law at (567) 455-5955. You can also contact Borgess Law by submitting an online inquiry. Again, this consultation is free and confidential. We welcome any questions you may have.